AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Court of appeals upholds patents on AZT. (Burroughs Wellcome Co.'s patents on zidovudine)
Burroughs Wellcome Co., Research Triangle Park, North Carolina, released the following on November 23, 1994:
The U.S. Court of Appeals for the Federal Circuit yesterday upheld a July 1993 district court judgment and affirmed Burroughs Wellcome scientists as the sole inventors on five of the six patents for the use of Retrovir brand zidovudine (AZT) as a treatment for HIV disease. A three-judge panel upheld the ruling of the District Court for the Eastern District of North Carolina as a matter of law in favor of Burroughs Wellcome Co. and against two generic drug manufacturers, Barr Laboratories, Inc., Novopharm, Inc. and Novopharm Ltd.
"On the facts before …
-
- FDA approves BARR Laboratories' generic AZT.
-
Newspaper article from: AIDS Weekly
March 13, 1995
700+ words
-
- Company vows to prove 'deceptive intent' on AZT patent no. 750. (Novopharm Ltd.)
-
Newspaper article from: AIDS Weekly
December 5, 1994
700+ words
-
- Inventorship: a significant effect on ownership and validity of an invention.
-
Magazine article from: The Licensing Journal
McConathy, Evelyn H.
May 1, 2006
700+ words
